TEMPUR-PEDIC REPORTS FOURTH QUARTER AND FULL YEAR EARNINGS
– Reports Fourth Quarter EPS of $0.38 |
– Company Announces $100 Million Share Repurchase Program |
LEXINGTON, KY, January 26, 2010 – Tempur-Pedic International Inc. (NYSE: TPX), the leading manufacturer, marketer and distributor of premium mattresses and pillows worldwide, today announced financial results for the fourth quarter and year ended December 31, 2009. The Company also announced a $100 million share repurchase program and confirmed its financial guidance for 2010.
FOURTH QUARTER FINANCIAL SUMMARY
| · | Earnings per share (EPS) were $0.38 per diluted share in the fourth quarter of 2009 as compared to adjusted EPS of $0.17 per diluted share in the fourth quarter of 2008. GAAP EPS in the fourth quarter of 2008 was $0.01, and reflects the $11.6 million tax provision related to the Company’s repatriation of foreign earnings. The Company reported net income of $29.1 million for the fourth quarter of 2009 as compared to adjusted net income of $12.7 million in the fourth quarter of 2008. GAAP net income in the fourth quarter of 2008 was $1.1 million. For additional information regarding adjusted EPS and adjusted net income (which are non-GAAP measures), please refer to the reconciliation and other information included in the attached schedule. |
| · | Net sales increased 29% to $244.8 million in the fourth quarter of 2009 from $189.1 million in the fourth quarter of 2008. On a constant currency basis, net sales increased 24%. Net sales in the domestic segment increased 40%, while international segment net sales increased 15%. On a constant currency basis, international segment net sales increased 3%. |
| · | Mattress sales increased 26% globally. Mattress sales increased 34% in the domestic segment and 12% in the international segment. On a constant currency basis, international mattress sales were essentially unchanged. Pillow sales increased 23% globally. Pillow sales increased 39% domestically and 13% internationally. On a constant currency basis, international pillow sales increased 1%. |
| · | Gross profit margin was 48.5% as compared to 43.0% in the fourth quarter of 2008. The gross profit margin increased as a result of improved efficiencies in manufacturing, lower commodity costs, fixed cost leverage related to higher production volumes and improved pricing, partially offset by geographic mix and new product introductions. |
| · | Operating profit margin was 19.3% as compared to 13.4% in the fourth quarter of 2008. |
| · | The Company generated $14.6 million of operating cash flow in the fourth quarter of 2009. |
| · | During the quarter, the Company reduced Total debt by $17.5 million to $297.5 million. As of December 31, 2009, the Company’s ratio of Funded debt to EBITDA was 1.68 times, well within the covenant in its credit facility, which requires that this ratio not exceed 3.00 times. For additional information about EBITDA and Funded debt (which are non-GAAP measures) please refer to the reconciliation and other information included in the attached schedule. |
FULL YEAR 2009 FINANCIAL SUMMARY
| · | Earnings per share (EPS) were $1.12 per diluted share for the full year 2009 as compared to adjusted EPS of $0.94 per diluted share for the full year 2008. GAAP EPS was $0.79 for the full year 2008, and includes the $11.6 million tax provision related to the repatriation of foreign earnings. |
| · | Net sales declined 10% to $831.2 million for the full year 2009 from $927.8 million for the full year 2008. On a constant currency basis, net sales declined 9%. Net sales in the domestic segment declined 8%, while international segment net sales declined 14%. On a constant currency basis, international segment net sales declined 11%. |
| · | Gross profit margin was 47.4% for the full year 2009 as compared to 43.2% for the full year 2008. The gross profit margin increased as a result of improved efficiencies in manufacturing, lower commodity costs, and improved pricing, partially offset by fixed cost de-leverage related to lower production volumes. |
| · | Operating profit margin was 17.4% as compared to 14.4% for the full year 2008. |
| · | For the full year 2009, the Company lowered Total debt by $121.9 million to $297.5 million. |
Chief Executive Officer Mark Sarvary commented, “Our fourth quarter and full year results reflect a gradual improvement in the macro environment together with success from sales and marketing initiatives. Our recent product introductions and our new advertising campaign combined with continued productivity improvements should allow us to build on this performance in 2010.”
Chief Financial Officer Dale Williams commented, “With respect to the authorization of a new share repurchase program, we note that during 2009 we substantially reduced both our total debt and leverage ratio. We view share repurchases as an excellent means to return value to stockholders over the long term.”
Share Repurchase Program
The Board of Directors authorized the repurchase of up to $100 million of shares of the Company’s common stock. Stock repurchases under this program may be made through open market transactions, negotiated purchases or otherwise, at times and in such amounts as management and a committee of the Board deem appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, financing and regulatory requirements and other market conditions. Repurchases may also be made under a Rule 10b5-1 plan, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so under insider trading laws. This share repurchase program replaces the Company’s prior share repurchase authorization, and may be limited, suspended or terminated at any time without prior notice.
Financial Guidance
The Company confirmed its full year 2010 guidance for net sales and earnings per share. It currently expects net sales for 2010 to range from $950 million to $970 million. It currently expects EPS for 2010 to range from $1.40 to $1.50 per diluted share. The Company noted its expectations are based on information available at the time of this release, and are subject to changing conditions, many of which are outside the Company’s control. The Company noted its EPS guidance does not assume any benefit from a potential reduction in shares outstanding related to its share repurchase program.
Conference Call Information
Tempur-Pedic International will host a live conference call to discuss financial results today, January 26, 2010 at 5:00 p.m. Eastern Time. The dial-in number for the conference call is 888-293-6960. The dial-in number for international callers is 719-325-2289. The call is also being webcast and can be accessed on the investor relations section of the Company's website, http://www.tempurpedic.com. After the conference call, a webcast replay will remain available on the investor relations section of the Company’s website for 30 days.
Forward-looking Statements
This release contains "forward-looking statements,” within the meaning of federal securities laws, which include information concerning one or more of the Company's plans, objectives, goals, strategies, and other information that is not historical information. When used in this release, the words "estimates," "expects," "anticipates," "projects," "plans," "intends," "believes," and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements relating to the Company’s expectations for building on its 2009 performance in 2010, and for net sales and earnings per share for 2010. All forward looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct.
There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the Company's control, could cause actual results to differ materially from those expressed as forward-looking statements. These risk factors include general economic, financial and industry conditions, particularly in the retail sector, as well as consumer confidence and the availability of consumer financing; uncertainties arising from global events; the effects of changes in foreign exchange rates on the Company’s reported earnings; consumer acceptance of the Company’s products; industry competition; the efficiency and effectiveness of the Company’s advertising campaigns and other marketing programs; the Company’s ability to increase sales productivity within existing retail accounts and to further penetrate the Company’s domestic retail channel, including the timing of opening or expanding within large retail accounts; the Company’s ability to address issues in certain underperforming international markets; the Company’s ability to continuously improve and expand its product line, maintain efficient, timely and cost-effective production and delivery of its products, and manage its growth; changes in foreign tax rates, including the ability to utilize tax loss carry forwards; and rising commodity costs. Additional information concerning these and other risks and uncertainties are discussed in the Company's filings with the Securities and Exchange Commission, including without limitation the Company's annual report on Form 10-K under the headings "Special Note Regarding Forward-Looking Statements" and "Risk Factors." Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements for any reason, including to reflect events or circumstances after the date on which such statements are made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
About the Company
Tempur-Pedic International Inc. (NYSE: TPX) manufactures and distributes mattresses and pillows made from its proprietary TEMPUR(R) pressure-relieving material. It is the worldwide leader in premium and specialty sleep. The Company is focused on developing, manufacturing and marketing advanced sleep surfaces that help improve the quality of life for people around the world. The Company's products are currently sold in over 80 countries under the TEMPUR(R) and Tempur-Pedic(R) brand names. World headquarters for Tempur-Pedic International is in Lexington, KY. For more information, visit http://www.tempurpedic.com or call 800-805-3635.
Investor Relations Contact:
Barry Hytinen
Vice President, Investor Relations and Financial Planning & Analysis
800-805-3635
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Consolidated Statements of Income
(In thousands, except per common share amounts)
| Three Months Ended | Twelve Months Ended | ||||||||||||||
| December 31, | December 31, | ||||||||||||||
| 2009 | 2008 | Chg % | 2009 | 2008 | Chg % | ||||||||||
| Net sales | $ | 244,794 | $ | 189,121 | 29% | $ | 831,156 | $ | 927,818 | (10%) | |||||
| Cost of sales | 125,953 | 107,752 | 437,414 | 526,861 | |||||||||||
| Gross profit | 118,841 | 81,369 | 46% | 393,742 | 400,957 | (2%) | |||||||||
| Selling and marketing expenses | 45,105 | 34,444 | 153,440 | 172,350 | |||||||||||
| General, administrative and other expenses | 26,510 | 21,604 | 95,357 | 94,743 | |||||||||||
| Operating income | 47,226 | 25,321 | 87% | 144,945 | 133,864 | 8% | |||||||||
| Other expense, net: | |||||||||||||||
| Interest expense, net | (3,990 | ) | (5,493 | ) | (17,349 | ) | (25,123 | ) | |||||||
| Other income (expense), net | 37 | (324 | ) | 441 | (1,319 | ) | |||||||||
| Total other expense | (3,953 | ) | (5,817 | ) | (16,908 | ) | (26,442 | ) | |||||||
| Income before income taxes | 43,273 | 19,504 | 122% | 128,037 | 107,422 | 19% | |||||||||
| Income tax provision | 14,159 | 18,449 | 43,044 | 48,554 | |||||||||||
| Net income | $ | 29,114 | $ | 1,055 | 2,660% | $ | 84,993 | $ | 58,868 | 44% | |||||
| Earnings per common share: | |||||||||||||||
| Basic | $ | 0.39 | $ | 0.01 | $ | 1.13 | $ | 0.79 | |||||||
| Diluted | $ | 0.38 | $ | 0.01 | $ | 1.12 | $ | 0.79 | |||||||
| Weighted average common shares outstanding: | |||||||||||||||
| Basic | 75,029 | 74,833 | 74,934 | 74,737 | |||||||||||
| Diluted | 77,028 | 74,920 | 76,048 | 74,909 | |||||||||||
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(In thousands)
| December 31, | December 31, | ||||||
| 2009 | 2008 | ||||||
| ASSETS | |||||||
| Current Assets: | |||||||
| Cash and cash equivalents | $ | 14,042 | $ | 15,385 | |||
| Accounts receivable, net | 105,576 | 99,811 | |||||
| Inventories | 57,686 | 60,497 | |||||
| Prepaid expenses and other current assets | 11,268 | 9,233 | |||||
| Deferred income taxes | 20,411 | 11,888 | |||||
| Total Current Assets | 208,983 | 196,814 | |||||
| Property, plant and equipment, net | 172,497 | 185,843 | |||||
| Goodwill | 193,391 | 192,569 | |||||
| Other intangible assets, net | 64,717 | 66,823 | |||||
| Other non-current assets | 3,791 | 4,482 | |||||
| Total Assets | $ | 643,379 | $ | 646,531 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Current Liabilities: | |||||||
| Accounts payable | $ | 47,761 | $ | 41,355 | |||
| Accrued expenses and other current liabilities | 81,452 | 65,316 | |||||
| Income taxes payable | 7,312 | 7,783 | |||||
| Total Current Liabilities | 136,525 | 114,454 | |||||
| Long-term debt | 297,470 | 419,341 | |||||
| Deferred income taxes | 29,865 | 28,371 | |||||
| Other non-current liabilities | 7,226 | 11,922 | |||||
| Total Liabilities | 471,086 | 574,088 | |||||
| Stockholders’ Equity: | |||||||
| Common stock, $.01 par value; 300,000 shares authorized; 99,215 shares issued as of December 31, 2009 and 2008, respectively | 992 | 992 | |||||
| Additional paid in capital | 298,842 | 291,018 | |||||
| Retained earnings | 365,727 | 281,422 | |||||
| Accumulated other comprehensive loss | (8,004 | ) | (12,590 | ) | |||
| Treasury stock at cost; 24,103 and 24,382 shares as of December 31, 2009 and 2008, respectively | (485,264 | ) | (488,399 | ) | |||
| Total Stockholders’ Equity | 172,293 | 72,443 | |||||
| Total Liabilities and Stockholders’ Equity | $ | 643,379 | $ | 646,531 | |||
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(In thousands)
| Twelve Months Ended | |||||||
| December 31, | |||||||
| 2009 | 2008 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net income | $ | 84,993 | $ | 58,868 | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Depreciation and amortization | 31,424 | 32,756 | |||||
| Amortization of stock-based compensation | 8,789 | 8,041 | |||||
| Amortization of deferred financing costs | 692 | 1,060 | |||||
| Bad debt expense | 5,936 | 8,110 | |||||
| Deferred income taxes | (9,810 | ) | 2,423 | ||||
| Foreign currency adjustments | (115 | ) | (1,183) | ||||
| Loss on sale of equipment and other | 564 | 666 | |||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | (10,542 | ) | 51,231 | ||||
| Inventories | 3,738 | 45,758 | |||||
| Prepaid expenses and other current assets | (1,884 | ) | 1,695 | ||||
| Accounts payable | 7,808 | (15,676 | ) | ||||
| Accrued expenses and other | 14,044 | 535 | |||||
| Income taxes payable | (651 | ) | 4,110 | ||||
| Net cash provided by operating activities | 134,986 | 198,394 | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Purchases of property, plant and equipment | (14,303 | ) | (10,494 | ) | |||
| Acquisition of business, net of cash acquired | — | (1,529 | ) | ||||
| Proceeds from escrow settlement | — | 7,141 | |||||
| Other | — | (486 | ) | ||||
| Net cash used by investing activities | (14,303 | ) | (5,368 | ) | |||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Proceeds from long-term revolving credit facility | 109,333 | 127,383 | |||||
| Repayments of long-term revolving credit facility | (230,036 | ) | (251,536 | ) | |||
| Repayments of long-term debt | — | (1,359 | ) | ||||
| Repayment of Series A Industrial Revenue Bonds | — | (57,785 | ) | ||||
| Proceeds from issuance of common stock | 1,623 | 695 | |||||
| Excess tax benefit from stock based compensation | 359 | 399 | |||||
| Dividend paid to stockholders | — | (17,933 | ) | ||||
| Other | — | (14 | ) | ||||
| Net cash used by financing activities | (118,721 | ) | (200,150) | ||||
| NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | (3,305 | ) | (10,806 | ) | |||
| Decrease in cash and cash equivalents | (1,343) | (17,930) | |||||
| CASH AND CASH EQUIVALENTS, beginning of period | 15,385 | 33,315 | |||||
| CASH AND CASH EQUIVALENTS, end of period | $ | 14,042 | $ | 15,385 | |||
Summary of Channel Sales
The Company generates sales through four distribution channels: retail, direct, healthcare and third party. The retail channel sells to furniture, specialty and department stores globally. The direct channel sells directly to consumers. The healthcare channel sells to hospitals, nursing homes, healthcare professionals and medical retailers. The third party channel sells to distributors in countries where Tempur-Pedic International does not operate its own distribution company.
The following table highlights net sales information, by channel and by segment, for the fourth quarter of 2009 compared to 2008:
| (In thousands) | ||||||||||||||||||||||||
| CONSOLIDATED | DOMESTIC | INTERNATIONAL | ||||||||||||||||||||||
| Three Months Ended | Three Months Ended | Three Months Ended | ||||||||||||||||||||||
| December 31, | December 31, | December 31, | ||||||||||||||||||||||
| 2009 | 2008 | 2009 | 2008 | 2009 | 2008 | |||||||||||||||||||
| Retail | $ | 205,184 | $ | 157,652 | $ | 130,808 | $ | 93,332 | $ | 74,376 | $ | 64,320 | ||||||||||||
| Direct | 16,719 | 10,098 | 14,777 | 8,496 | 1,942 | 1,602 | ||||||||||||||||||
| Healthcare | 10,047 | 10,638 | 2,840 | 3,226 | 7,207 | 7,412 | ||||||||||||||||||
| Third Party | 12,844 | 10,733 | 3,444 | 3,342 | 9,400 | 7,391 | ||||||||||||||||||
| Total | $ | 244,794 | $ | 189,121 | $ | 151,869 | $ | 108,396 | $ | 92,925 | $ | 80,725 | ||||||||||||
Summary of Product Sales
A summary of net sales by product is reported below:
| (In thousands) | ||||||||||||||||||||||||
| CONSOLIDATED | DOMESTIC | INTERNATIONAL | ||||||||||||||||||||||
| Three Months Ended | Three Months Ended | Three Months Ended | ||||||||||||||||||||||
| December 31, | December 31, | December 31, | ||||||||||||||||||||||
| 2009 | 2008 | 2009 | 2008 | 2009 | 2008 | |||||||||||||||||||
| Mattresses | $ | 156,665 | $ | 124,755 | $ | 101,792 | $ | 75,695 | $ | 54,873 | $ | 49,060 | ||||||||||||
| Pillows | 32,079 | 25,990 | 14,724 | 10,591 | 17,355 | 15,399 | ||||||||||||||||||
| Other | 56,050 | 38,376 | 35,353 | 22,110 | 20,697 | 16,266 | ||||||||||||||||||
| Total | $ | 244,794 | $ | 189,121 | $ | 151,869 | $ | 108,396 | $ | 92,925 | $ | 80,725 | ||||||||||||
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Reconciliation of Adjusted Net income, Adjusted Earnings per share,
EBITDA to Net Income and Funded debt to Total debt
Non-GAAP Measures
(In thousands, except per common share amounts)
The Company provides information regarding Adjusted Net income, Adjusted Earnings per share, EBITDA and Funded debt which are not recognized terms under GAAP (Generally Accepted Accounting Principles) and do not purport to be alternatives to Net income as a measure of operating performance or Total debt. Because not all companies use identical calculations, these presentations may not be comparable to other similarly titled measures of other companies. A reconciliation of Adjusted Net income, Adjusted Earnings per share and EBITDA to the Company’s Net income and Earnings per share and a reconciliation of Funded debt to Total debt are provided below. Management believes that the use of these non-GAAP financial measures provides investors with additional useful information with respect to the impact of the repatriation of foreign earnings. Management also believes that the use of EBITDA and Funded debt provides investors with useful information with respect to the terms of the Company’s credit facility.
Reconciliation of Adjusted Net income to Net income
The following table sets forth the reconciliation of the Company’s reported Net income for the twelve months ended December 31, 2008 to the calculation of Adjusted Net income for the three and twelve months ended December 31, 2008:
| Three Months Ended | Twelve Months Ended | |||||||
| December 31, 2008 | December 31, 2008 | |||||||
| GAAP Net income | $ | 1,055 | $ | 58,868 | ||||
| Plus: | ||||||||
| Tax provision related to repatriation of foreign earnings | 11,631 | 11,631 | ||||||
| Adjusted Net income | $ | 12,686 | $ | 70,499 | ||||
| GAAP Earnings per share, diluted | $ | 0.01 | $ | 0.79 | ||||
| Tax provision related to repatriation of foreign earnings | 0.16 | 0.15 | ||||||
| Adjusted Earnings per share, diluted | $ | 0.17 | $ | 0.94 | ||||
Reconciliation of EBITDA to Net income
The following table sets forth the reconciliation of the Company’s reported Net income to the calculation of EBITDA for the twelve months ended December 31, 2009:
| Twelve Months Ended | ||||
| December 31, 2009 | ||||
| GAAP Net income | $ | 84,993 | ||
| Plus: | ||||
| Interest expense | 17,349 | |||
| Income taxes | 43,044 | |||
| Depreciation & amortization | 40,213 | |||
| EBITDA | $ | 185,599 | ||
Reconciliation of Funded debt to Total debt
The following table sets forth the reconciliation of the Company’s reported Total debt to the calculation of Funded debt as of December 31, 2009:
| As of | ||||
| December 31, 2009 | ||||
| GAAP basis Total debt | $ | 297,470 | ||
| Plus: | ||||
| Letters of credit outstanding | 14,048 | |||
| Funded debt | $ | 311,518 | ||
Calculation of Funded debt to EBITDA
| As of | ||||
| December 31, 2009 | ||||
| Funded debt | $ | 311,518 | ||
| EBITDA | 185,599 | |||
| 1.68 times | ||||